Pneumonia Testing Market Trends

  • Report ID: 4457
  • Published Date: Aug 19, 2025
  • Report Format: PDF, PPT

Pneumonia Testing Market - Growth Drivers and Challenges

Growth Drivers

  • Automation in diagnostics: The integration of artificial intelligence in health diagnostics tends to reduce the overall treatment duration, which is suitable for augmenting the pneumonia testing market globally. According to an article published by NLM in September 2023, the aspect of machine learning-deep learning algorithm demonstrated a characteristic curve of 95%, along with 77.3% specificity, and 87% of sensitivity. Besides, the utilization of AI systems in healthcare has been suitable for 101 radiologists, showcasing 86.4% sensitivity and 87.5% specificity, thus positively impacting the overall market.

  • Air pollution impact: An increase in pneumonia cases is highly denoted by a surge in air pollution internationally, which has bolstered the pneumonia testing market demand. As per the 2025 WHO report, 99% of the global population breathe air that comprises harmful pollutants, with developing countries suffering the most from high exposures. Besides, the April 2025 NIH report stated that over 6.5 million deaths take place every year, denoting an increase over the past two decades. From vehicle emissions to natural gas, fuel oils, and power generation, especially from coal-based power facilities, are creating increased pollution, which in turn is increasing pneumonia, and hence an increase in the market demand.

  • Expansion in travel medicine: Travelers returning from international destinations are possible carriers of respiratory illness, leading to pneumonia cases, which in turn is driving the pneumonia testing market. As stated in the April 2025 NLM article, 36% infections are caused during travelling, which has resulted in the increased need for travel medicines. Besides, the March 2023 Medscape report indicated that over 1.4 billion travelers have crossed international borders, in comparison to 25 million in previous years, thereby denoting the requirement for travel health clinics, which is positively impacting the market.

X-Ray (including CT-Scan) Sourcing for the Pneumonia Testing Market

X-Ray Import and Export Global Data

Countries

Export

Import

U.S.

USD 3.5 million

USD 33.9 million

Germany

USD 1.0 million

USD 11.8 million

Bangladesh

USD 763,000

-

Brazil

USD 650,000

-

Egypt

USD 603,000

-

China

-

USD 49.1 million

Japan

-

USD 20.1 million

Israel

-

USD 3.4 million

Source: OEC, 2023

Severity Scoring Systems Impacting the Pneumonia Testing Market

CRB65 and CURB65 Scoring Systems Comparison

Component

CRB65 Score (Community Setting)

CURB65 Score (Hospital Setting)

Confusion

Abbreviated Mental Test ≤8 or new disorientation

Same as community

Raised Respiratory Rate

≥30 breaths/min

Same as community

Low Blood Pressure

Diastolic ≤60 mmHg or Systolic <90 mmHg

Same as community

Age

≥65 years

Same as community

Blood Urea Nitrogen (BUN)

Not applicable

>7 mmol/L

Total Possible Points

4

5

Source: NLM, October 2023

Challenges

  • Increased out-of-pocket expenses: Pneumonia testing costs are creating financial gaps, particularly for underinsured and uninsured patients. For instance, the cash price range for molecular tests denotes a crippling expense for the majority of uninsured patients in America. Besides, the situation is even worse in developing nations, where tests are usually more than a week’s wage. This has resulted in diagnostic and treatment delays, thereby increasing the mortality rate. However, rapid test adoption, partnership with government organizations are probable solutions for this issue, which is suitable for the pneumonia testing market’s upliftment.

  • Disruptions in the supply chain: The pneumonia testing market continues to remain vulnerable to critical bottlenecks in the supply chain that can affect the production process. Severe components, such as specialized plastics, nitrocellulose membranes for rapid tests, and PCR reagents, are sourced from other nations, including the U.S., Germany, and China. Therefore, this concentration has created huge risks, leading to delays in test manufacturers, particularly to produce molecular tests that usually require specialized components from different suppliers, thus causing a hindrance in the market’s growth.


Base Year

2025

Forecast Year

2026-2035

CAGR

7.2%

Base Year Market Size (2025)

USD 2.5 billion

Forecast Year Market Size (2035)

USD 4.6 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the pneumonia testing market was over USD 2.5 billion.

The market size for the pneumonia testing market is projected to reach USD 4.6 billion by the end of 2035 expanding at a CAGR of 7.2% during the forecast period i.e., between 2026-2035.

The major players in the market are Roche, Abbott, Thermo Fisher, BioMérieux, BD Global, and others.

In terms of the end user segment, the hospitals and clinics segment is anticipated to garner the largest market share of 45.8% by 2035 and display lucrative growth opportunities during 2026-2035.

The market in North America is projected to hold the largest market share of 38.3% by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos